Development of an EORTC quality of life phase III module measuring cancer-related fatigue (EORTC QLQ-FA13) - Université de Lorraine Accéder directement au contenu
Article Dans Une Revue Psycho-Oncology Année : 2013

Development of an EORTC quality of life phase III module measuring cancer-related fatigue (EORTC QLQ-FA13)

Résumé

BACKGROUND: European Organisation for Research and Treatment of Cancer (EORTC) has developed a new multidimensional instrument measuring cancer-related fatigue that can be used in conjunction with the quality of life core questionnaire, EORTC QLQ-C30. The paper focuses on the development of the phase III module, collaborating with seven European countries, including a patient sample of 318 patients. METHODS: The methodology followed the EORTC guidelines for developing phase III modules. Patients were assessed by questionnaires (EORTC QLQ-C30 with the EORTC Fatigue Module FA15) followed by an interview, asking for their opinions on the difficulty in understanding, on annoyance and on intrusiveness. RESULTS: The phase II FA15 was revised on the basis of qualitative analyses (comments of the patients), quantitative results (descriptive statistics) as well as the multi-item response theory analyses. The three dimensions (physical, emotional and cognitive) of the scale could be confirmed. CONCLUSIONS: As a result, EORTC QLQ-FA13 is now available as a valid phase III module measuring cancer-related fatigue in clinical trials and will be psychometrically improved in the upcoming phase IV.

Dates et versions

hal-01794186 , version 1 (17-05-2018)

Identifiants

Citer

Joachim Weis, Juan Ignacio Arraras, Thierry Conroy, Fabio Efficace, Claudia Fleissner, et al.. Development of an EORTC quality of life phase III module measuring cancer-related fatigue (EORTC QLQ-FA13). Psycho-Oncology, 2013, 22 (5), pp.1002 - 1007. ⟨10.1002/pon.3092⟩. ⟨hal-01794186⟩
119 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More